Orla Morrissey

988 total citations
26 papers, 329 citations indexed

About

Orla Morrissey is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Orla Morrissey has authored 26 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 13 papers in Infectious Diseases and 5 papers in Surgery. Recurrent topics in Orla Morrissey's work include Antifungal resistance and susceptibility (11 papers), Fungal Infections and Studies (10 papers) and Mycobacterium research and diagnosis (7 papers). Orla Morrissey is often cited by papers focused on Antifungal resistance and susceptibility (11 papers), Fungal Infections and Studies (10 papers) and Mycobacterium research and diagnosis (7 papers). Orla Morrissey collaborates with scholars based in Australia, United States and Canada. Orla Morrissey's co-authors include Monica A. Slavin, David C. M. Kong, Karin Thursky, Roger L. Nation, Sharon C.‐A. Chen, Renée Manser, Shahid Husain, Me‐Linh Luong, Chin Fen Neoh and Senthil Lingaratnam and has published in prestigious journals such as Blood, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Orla Morrissey

24 papers receiving 321 citations

Peers

Orla Morrissey
R. Schulten Germany
Dana M. Harris United States
Mirjam Faes Hesse Switzerland
Mona Al-Dabbagh Saudi Arabia
Carlos Mejía-Chew United States
Ashrit Multani United States
Jerry D. Peterie United States
R. Schulten Germany
Orla Morrissey
Citations per year, relative to Orla Morrissey Orla Morrissey (= 1×) peers R. Schulten

Countries citing papers authored by Orla Morrissey

Since Specialization
Citations

This map shows the geographic impact of Orla Morrissey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orla Morrissey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orla Morrissey more than expected).

Fields of papers citing papers by Orla Morrissey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orla Morrissey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orla Morrissey. The network helps show where Orla Morrissey may publish in the future.

Co-authorship network of co-authors of Orla Morrissey

This figure shows the co-authorship network connecting the top 25 collaborators of Orla Morrissey. A scholar is included among the top collaborators of Orla Morrissey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orla Morrissey. Orla Morrissey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aslam, Saima, Jennifer Cowger, Palak Shah, et al.. (2024). The International Society for Heart and Lung Transplantation (ISHLT): 2024 infection definitions for durable and acute mechanical circulatory support devices. The Journal of Heart and Lung Transplantation. 43(7). 1039–1050. 14 indexed citations
2.
Gardiner, Bradley J., et al.. (2022). Incidence and Severity of Cytomegalovirus Infection in Seropositive Heart Transplant Recipients. The Journal of Heart and Lung Transplantation. 41(4). S278–S279. 1 indexed citations
3.
Corallo, Carmela, et al.. (2020). Dementia-Like Symptoms Associated With Posaconazole. Journal of Pharmacy Practice. 35(1). 135–139. 4 indexed citations
4.
Corallo, Carmela, John Coutsouvelis, Susan Morgan, Orla Morrissey, & Sharon Avery. (2020). Dapsone for Pneumocystis jirovecii pneumonia prophylaxis – applying theory to clinical practice with a focus on drug interactions. Drug metabolism and drug interactions. 35(3). 1 indexed citations
5.
Boyce, Kylie J., Orla Morrissey, Alexander Idnurm, & Ian Macreadie. (2019). Insights into the global emergence of antifungal drug resistance. Microbiology Australia. 40(2). 87–91. 7 indexed citations
6.
7.
Morrissey, Orla, Rongbing Xie, Joanna Schaenman, et al.. (2017). Epidemiology of Fungal Infections (FI) in Mechanical Circulatory Support Device (MCSD) Recipients: Analysis of IMACS Registry 2013-2015. The Journal of Heart and Lung Transplantation. 36(4). S27–S27. 1 indexed citations
8.
Dalgaard, Lars, Mette Nørgaard, Johan Vestergaard Povlsen, et al.. (2016). Risk and prognosis of bacteremia and fungemia among first-time kidney transplant recipients: a population-based cohort study. Infectious Diseases. 49(4). 286–295. 6 indexed citations
9.
Barnes, Rosemary A., Stephanie Earnshaw, Raoul Herbrecht, et al.. (2015). Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients. Clinical Therapeutics. 37(6). 1317–1328.e2. 26 indexed citations
10.
Saxena, Pankaj, et al.. (2015). Challenges in the management of invasive pulmonary zygomycosis: the Alfred experience. ANZ Journal of Surgery. 85(10). 700–701. 5 indexed citations
11.
Neoh, Chin Fen, Gregory I. Snell, Bronwyn Levvey, et al.. (2014). Lung transplant recipients receiving voriconazole and skin squamous cell carcinoma risk in Australia. The Medical Journal of Australia. 201(9). 543–544. 9 indexed citations
12.
Morrissey, Orla, Sharon C.‐A. Chen, Karin Thursky, et al.. (2013). Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: A systematic review and meta-analysis. Critical Reviews in Microbiology. 41(1). 124–134. 90 indexed citations
13.
Snell, Gregory I., Bronwyn Levvey, D. Keating, et al.. (2013). Relationship between Trough Plasma and Epithelial Lining Fluid Concentrations of Voriconazole in Lung Transplant Recipients. Antimicrobial Agents and Chemotherapy. 57(9). 4581–4583. 16 indexed citations
14.
Neoh, Chin Fen, Danny Liew, Monica A. Slavin, et al.. (2013). Economic evaluation of micafungin vs. Liposomal Amphotericin B (LAmB) for the treatment of candidaemia and Invasive Candidiasis (IC). Mycoses. 56(5). 532–542. 9 indexed citations
15.
Morrissey, Orla, G. Snell, Bronwyn Levvey, et al.. (2013). Effect of Therapeutic Drug Monitoring (TDM) on the Efficacy and Safety of Pre-Emptive Voriconazole in Lung Transplant Recipients. The Journal of Heart and Lung Transplantation. 32(4). S189–S189. 1 indexed citations
16.
Lingaratnam, Senthil, Monica A. Slavin, Bogda Koczwara, et al.. (2011). Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Internal Medicine Journal. 41(1b). 75–81. 29 indexed citations
17.
Neoh, Chin Fen, Danny Liew, Monica A. Slavin, et al.. (2011). Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis. Journal of Antimicrobial Chemotherapy. 66(8). 1906–1915. 24 indexed citations
18.
Lingaratnam, Senthil, Monica A. Slavin, Linda Mileshkin, et al.. (2011). An Australian survey of clinical practices in management of neutropenic fever in adult cancer patients 2009. Internal Medicine Journal. 41(1b). 110–120. 24 indexed citations
19.
Luong, Me‐Linh, Orla Morrissey, & Shahid Husain. (2010). Assessment of infection risks prior to lung transplantation. Current Opinion in Infectious Diseases. 23(6). 578–583. 19 indexed citations
20.
Morrissey, Orla. (1995). Shifting Paradigms. Evaluation. 1(2). 217–235. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026